NOD mouse model for Sjögren's syndrome: Lack of longitudinal stability

Oral Diseases

Volumn 12, Issue 6, 2006, Pages 566-572

  Lodde, B M ^a,b   Mineshiba, F ^a   Kok, M R ^a,b   Wang, J ^a,c   Zheng, C ^a   Schmidt, M ^a   Cotrim, A P ^a   Kriete, M ^a   Tak, P P ^b   Baum, B J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; NOD mouse model; Phenotype; Salivary gland; Sj gren's syndrome

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; GAMMA INTERFERON; GLUCOSE; INSULIN ZINC SUSPENSION; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PARVOVIRUS VECTOR; PILOCARPINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENE THERAPY; GLUCOSE BLOOD LEVEL; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; INSULIN DEPENDENT DIABETES MELLITUS; LACRIMAL GLAND DISEASE; MEASUREMENT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVARY GLAND DISEASE; SALIVATION; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; INTERFERON TYPE II; INTERLEUKINS; LAC OPERON; LONGITUDINAL STUDIES; MICE; MICE, INBRED NOD; PHENOTYPE; SALIVA; SECRETORY RATE; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750343164     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01241.x     Document Type: Article

References (34)

1. Ader DN, Johnson SB, Huang SW, Riley WJ (1991). Group size, cage shelf level, and emotionality in non-obese diabetic mice: impact on onset and incidence of IDDM. Psychosom Med 53: 313-321.
2. Anderson MS and Bluestone JA (2005). The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.
3. Baxter AG, Koulmanda M, Mandel TE (1991). High and low diabetes incidence nonobese diabetic (NOD) mice: origins and characterisation. Autoimmunity 9: 61-67.
4. Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2003). Immunopathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 25: 89-104.
5. Bowman MA, Leiter EH, Atkinson MA (1994). Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol Today 15: 115-120.
6. Braddon VR, Chiorini JA, Wang S, Kotin RM, Baum BJ (1998). Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. Hum Gene Ther 9: 2777-2785.
7. Cha S, Peck AB, Humphreys-Beher MG (2002a). Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update. Crit Rev Oral Biol Med 13: 5-16.
8. Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG (2002b). Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background. Arthritis Rheum 46: 1390-1398.
9. Chiorini JA, Wendtner CM, Urcelay E, Safer B, Hallek M, Kotin RM (1995). High-efficiency transfer of the T cell costimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther 6: 1531-1541.
10. Conlon TJ, Flotte TR (2004). Recombinant adeno-associated virus vectors for gene therapy. Expert Opin Biol Ther 4: 1093-1101.
11. Di Pasquale G, Davidson BL, Stein CS et al (2003). Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med 9: 1306-1312.
12. Durant S, Coulaud J, Amrani A, de Hasnaoui A, Dardenne M, Homo-Delarche F (1993). Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type 1 diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun 6: 735-751.
13. Elliott RB, Reddy SN, Bibby NJ, Kida K (1988). Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia 31: 62-64.
14. Greenspan JS, Daniels TE, Talal N, Sylvester RA (1974). The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 37: 217-229.
15. Humphreys-Beher MG, Peck AB (1999). New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol 44 (Suppl. 1): S21-S25.
16. Johansson AC, Nakken B, Sundler M et al (2002). The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur J Immunol 32: 243-250.
17. Johansson AC, Lindqvist AK, Johannesson M, Holmdahl R (2003). Genetic heterogeneity of autoimmune disorders in the nonobese diabetic mouse. Scand J Immunol 57: 203-213.
18. Jonsson R, Hagan H-J, Gordon T (2001). Sjögren's syndrome. In: Koopman WJ, ed. Arthritis and allied conditions - a textbook of rheumatology, 14th edn. Lippincott Williams & Wilkins: Philadelphia, pp. 1736-1759.
19. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA (2001). Adeno associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 75: 6884-6893.
20. Katano H, Kok MR, Cotrim AP et al (2006). Enhanced transduction of mouse salivary glands with AAV5 based vectors. Gene Ther 13: 594-601.
21. Kok MR, Baum BJ, Tak PP, Pillemer SR (2003a). Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome. Ann Rheum Dis 62: 1038-1046.
22. Kok MR, Yamano S, Lodde BM et al (2003b). Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren's syndrome. Hum Gene Ther 14: 1605-1618.
23. Lai CM, Lai YK, Rakoczy PE (2002). Adenovirus and adeno-associated virus vectors. DNA Cell Biol 21: 895-913.
24. Lehman CD, Rodin J, McEwen B, Brinton R (1991). Impact of environmental stress on the expression of insulin-dependent diabetes mellitus. Behav Neurosci 105: 241-245.
25. Leiter EH (1989). The genetics of diabetes susceptibility in mice. FASEB J 3: 2231-2241.
26. Leiter EH, Serreze DV, Prochazka M (1990). The genetics and epidemiology of diabetes in NOD mice. Immunol Today 11: 147-149.
27. Lodde BM, Mineshiba F, Wang J et al (2006). Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Ann Rheum Dis 65: 195-200.
28. Mazelis AG, Albert D, Crisa C et al (1987). Relationship of stressful housing conditions to the onset of diabetes mellitus induced by multiple, sub-diabetogenic doses of streptozotocin in mice. Diabetes Res 6: 195-200.
29. Ohsugi T, Kurosawa T (1994). Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. Lab Anim Sci 44: 386-388.
30. Paxson JA, Weber JG, Kulczycki A Jr (1997). Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes 46: 1711-1717.
31. Raz I, Eldor R, Naparstek Y (2005). Immune modulation for prevention of type 1 diabetes mellitus. Trends Biotechnol 23: 128-134.
32. Voutetakis A, Kok MR, Zheng C et al (2004). Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci U S A 101: 3053-3058.
33. Yamano S, Atkinson JC, Baum BJ, Fox PC (1999). Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin Immunol 92: 265-275.
34. Yamano S, Huang LY, Ding C et al (2002). Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum Gene Ther 13: 287-298.